|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Brigham and Women's Hospital Sanofi-Aventis |
|---|---|
| Information provided by: | Brigham and Women's Hospital |
| ClinicalTrials.gov Identifier: | NCT00604370 |
Purpose
An investigator initiated study exploring VTE prophylaxis at the time of hospital discharge.
| Condition |
|---|
|
Venous Thromboembolism |
| Study Type: | Observational |
| Study Design: | Case Control, Retrospective |
| Official Title: | VTE Prophylaxis Across the Continuum of Care: High Risk Patients at Hospital Discharge |
| Enrollment: | 2500 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | February 2010 |
| Estimated Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Acutely ill medical and surgical patients who were hospitalized at BWH, and at-risk for VTE, but were not treated with prophylaxis at hospital discharge.
|
|
2
Acutely ill medical and surgical patients who were at risk for VTE at time of hospital discharge and prescribed a prophylaxis strategy.
|
It appears likely that many patients will remain at risk for VTE at the time of hospital discharge. These risks will go unrecognized, and discharge prophylaxis orders will not be prescribed.
To test this hypothesis, we will perform a retrospective review of approximately 2,500 patients at Brigham and Women's Hospital at risk for VTE at the time of hospital discharge to determine what proportion received VTE prophylaxis. We will correlate the implementation of discharge VTE prophylaxis with the occurrence of symptomatic DVT and pulmonary embolism within 90 days of hospital discharge.
Eligibility| Ages Eligible for Study: | 17 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Acutely ill medical and surgical patients who were hospitalized at BWH and who are at risk for DVT.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations More Information
| Responsible Party: | Brigham and Women's Hospital ( Samuel Z. Goldhaber, MD ) |
| Study ID Numbers: | 2006-P-001981 |
| Study First Received: | December 28, 2007 |
| Last Updated: | January 29, 2008 |
| ClinicalTrials.gov Identifier: | NCT00604370 |
| Health Authority: | United States: Institutional Review Board |
|
Embolism and Thrombosis Embolism Vascular Diseases |
Venous Thromboembolism Thrombosis Thromboembolism |
|
Cardiovascular Diseases |
